FiercePharmaMore from FiercePharmaIndustrial ManufacturingU.K. May Be Leaving EU, But GlaxoSmithKline Isn't Leaving U.K.GlaxoSmithKline is not planning to exit the U.K. just because the U.K. is exiting the European Union. As if to emphasize its commitment, the drugmaker said it intends to put a big chunk of money into expanding its manufacturing there.August 1, 2016Global Supply Chain ManagementChina Inches Closer to Tougher Oversight on Pharmaceutical ManufacturingChina's efforts in good manufacturing practice certification in 2015 showed a continued shift toward warning letters even as the overall number of reviewed applications fell by more than half.June 10, 2016All TechnologyMerck Suffers Drug Supply Interruption Headache - AgainMerck & Co. is facing another supply interruption for its ovulation-stimulating hormone Follistim, and like the supply lapse from several years ago, Merck has little to say.June 8, 2016All TechnologyWalmart, McKesson Team to Jointly Buy Generic MedicinesRetailing giant Walmart and global drug wholesaler McKesson would both like to improve their bottom lines and think that pooling their purchasing power for generic meds can help them do that.May 20, 2016SC Finance & Revenue ManagementAs Its Top Drug Loses Patent Protection, Astra-Zeneca Revamps Supply ChainAstraZeneca's leadership gets ready to set out on a $1.5bn cost-cutting effort, the London pharma's manufacturing operations are in the cross-hairs.May 5, 2016Previous PagePage 2 of 2
